Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E927A SCHEMBL9921280 | 0.84 | — | — | |
| E927A SCHEMBL5599354 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP3A4HPGDEHMT2HSD17B10 | |
| E927A SCHEMBL26646 | 0.84 | — | — | |
| E927A SCHEMBL36851 | 0.84 | — | — | |
| E927A SCHEMBL11842709 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP3A4HPGDEHMT2HSD17B10 | |
| E927A SCHEMBL28536162 | 0.81 | — | — | |
| E927A SCHEMBL4576263 | 0.81 | — | — | |
| E927A SCHEMBL28500344 | 0.81 | — | — | |
| E927A SCHEMBL28486798 | 0.81 | — | — | |
| E927A SCHEMBL5072650 | 0.81 | ALDH1A1 (0.91) | ALDH1A1CYP3A4HPGDEHMT2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234594-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC | 2022-06-30 | — | — | US | disclosed |
| US-20220073715-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-03-10 | — | — | US | disclosed |
| US-20220073658-A1 | TELECHELIC POLYOLEFINS AND PROCESSES FOR PREPARING THE SAME | DOW GLOBAL TECHNOLOGIES LLC | 2022-03-10 | — | — | US | disclosed |
| US-20220056252-A1 | CROSS-LINKED FOAMS MADE FROM INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-02-24 | — | — | US | disclosed |
| EP-3902808-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3902810-A1 | CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS | Dow Global Technologies LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3902871-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3902867-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3902868-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2021-11-03 | — | — | EP | disclosed |
| US-20100056714-A1 | FARNESENE INTERPOLYMERS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100056743-A1 | POLYFARNESENES | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| US-7666918-B2 | Foams made from interpolymers of ethylene/α-olefins | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2010-02-23 | — | — | US | disclosed |
| US-7557147-B2 | Multiblock copolymers comprising soft segments and hard segments and specified physical properties; use as acoustical insulation, vibration control, cushioning, specialty packaging, automotive soft touch, thermal insulation or impact absorption; gloss retention, abrasion resistance | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1861454-A1 | FOAMS MADE FROM INTERPOLYMERS OF ETHYLENE/ alpha-OLEFINS | Dow Global Technologies Inc. (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1858960-A1 | SOFT FOAMS MADE FROM INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS | Dow Global Technologies Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006102151-A1 | SOFT FOAMS MADE FROM INTERPOLYMERS OF ETHYLENE/ALPHA-OLEFINS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006099631-A1 | FOAMS MADE FROM INTERPOLYMERS OF ETHYLENE/α-OLEFINS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| US-20060205833-A1 | Soft foams made from interpolymers of ethylene/alpha-olefins | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-14 | — | — | US | disclosed |
| US-20060199872-A1 | Foams made from interpolymers of ethylene/alpha-olefins | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | ACSL6, ELOVL6, ALOX5 | ALDH1A1 2201/4885CYP3A4 1801/4885HPGD 1707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.